Rhegen Biotech has developed an industry-leading, comprehensive technology platform for product development that essentially covers the entire spectrum of mRNA technologies and key components. This achievement is the result of years of steadfast strategic execution and R&D efforts, aimed at addressing unmet clinical treatment or prevention needs across a broad disease spectrum including oncology, major infectious diseases, autoimmune disorders, and metabolic diseases, while ensuring the success of all developed products in terms of drug-like properties and differentiated competitive advantages.

The company has accumulated a portfolio of over 310 global patents, demonstrating extensive and in-depth coverage of core mRNA domains and critical processes, all supported by complete independent intellectual property rights. The platform's capabilities and the drugability of its products have been validated through product development and clinical recognition by major global regulatory authorities including the NMPA, FDA, and TGA.

Rhegen Biotech's end-to-end, systematic mRNA technology platform ensures the development of high-quality products with strong competitive advantages for the global market. Leveraging this efficient platform, the company has advanced seven candidates with differentiated competitive profiles into clinical stages or gained clinical trial approvals, spanning areas such as oncology, major infectious diseases, and degenerative diseases.

The logical architecture of Rhegen Biotech's product development technology platform system is structured as follows:

One Objective:

To consistently focus on product development goals formed around addressing unmet clinical treatment or prevention needs within the disease spectrum.

One Principle:

To steadfastly adhere to the principle of drugability (ensuring safety, efficacy, and quality controllability).

Three Logical Layers:

Application Layer/ Technology Layer/ Fundamental Elements Layer

These three layers operate in an integrated manner: the Application Layer drives demand from the top down, while the Fundamental Elements Layer enables systematic support from the bottom up.